Avalo Therapeutics, Inc. (AVTX)
NASDAQ: AVTX · Real-Time Price · USD
12.98
+0.12 (0.93%)
Apr 29, 2026, 12:58 PM EDT - Market open

Avalo Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020 - 2016
Period Ending
Apr '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 2020 - 2016
Market Capitalization
34732978747191
Upgrade
Market Cap Growth
563.01%323.58%965.79%-84.63%-75.15%-95.47%
Upgrade
Enterprise Value
246218-1-152153
Upgrade
Last Close Price
12.8618.167.439.101209.614895.96
Upgrade
PS Ratio
5822.825581.57176.293.792.6335.37
Upgrade
PB Ratio
2.873.970.581.00-4.358.27
Upgrade
P/TBV Ratio
4.744.540.63--22.11
Upgrade
EV/Sales Ratio
4163.353699.17--2.8728.36
Upgrade
Debt / Equity Ratio
0.010.010.010.26-1.981.53
Upgrade
Net Debt / Equity Ratio
-1.18-1.18-1.00-0.75-0.78-0.83
Upgrade
Net Debt / EBITDA Ratio
1.351.353.280.24-0.280.24
Upgrade
Net Debt / FCF Ratio
1.901.902.720.18-0.320.27
Upgrade
Asset Turnover
000.010.070.320.09
Upgrade
Inventory Turnover
----896.212444.83
Upgrade
Quick Ratio
7.607.6019.331.640.682.99
Upgrade
Current Ratio
8.148.1419.951.820.743.11
Upgrade
Return on Equity (ROE)
-72.44%-72.44%-50.06%--684.77%-354.08%
Upgrade
Return on Assets (ROA)
-34.12%-34.12%-29.75%-53.91%-32.95%-82.82%
Upgrade
Return on Invested Capital (ROIC)
---6834.61%--4261.92%-1501.54%
Upgrade
Return on Capital Employed (ROCE)
-70.40%-70.40%-28.40%-143.20%-266.10%-136.20%
Upgrade
Earnings Yield
-22.78%-23.76%-45.18%-432.43%-87.80%-44.19%
Upgrade
FCF Yield
-14.98%-15.63%-63.10%-422.75%-56.58%-37.19%
Upgrade
Buyback Yield / Dilution
-78.82%-78.82%-2599.19%-608.45%-8.32%-41.86%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.